GB201403630D0 - Treatment of cystic fibrosis with alginate oligomers - Google Patents
Treatment of cystic fibrosis with alginate oligomersInfo
- Publication number
- GB201403630D0 GB201403630D0 GB201403630A GB201403630A GB201403630D0 GB 201403630 D0 GB201403630 D0 GB 201403630D0 GB 201403630 A GB201403630 A GB 201403630A GB 201403630 A GB201403630 A GB 201403630A GB 201403630 D0 GB201403630 D0 GB 201403630D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- cystic fibrosis
- alginate oligomers
- oligomers
- alginate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201403630A GB201403630D0 (en) | 2014-02-28 | 2014-02-28 | Treatment of cystic fibrosis with alginate oligomers |
PCT/EP2015/054207 WO2015128495A1 (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
JP2016554405A JP2017510563A (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other pathologies associated with defective CFTR ion channel function |
CN201580010273.7A CN106029079A (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
US15/121,671 US20160361342A1 (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
AU2015222051A AU2015222051A1 (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective CFTR ion channel function |
KR1020167026840A KR20160119259A (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
CA2940560A CA2940560A1 (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
RU2016136449A RU2016136449A (en) | 2014-02-28 | 2015-02-27 | APPLICATION OF ALGINATE OLIGOMETES IN THE TREATMENT OF MUKOVISCIDOSIS AND OTHER CONDITIONS ASSOCIATED WITH THE DISTURBED FUNCTION OF CFTR ION CHANNELS |
EP15708474.0A EP3110426A1 (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201403630A GB201403630D0 (en) | 2014-02-28 | 2014-02-28 | Treatment of cystic fibrosis with alginate oligomers |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201403630D0 true GB201403630D0 (en) | 2014-04-16 |
Family
ID=50490631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201403630A Ceased GB201403630D0 (en) | 2014-02-28 | 2014-02-28 | Treatment of cystic fibrosis with alginate oligomers |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201403630D0 (en) |
-
2014
- 2014-02-28 GB GB201403630A patent/GB201403630D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181692T1 (en) | Treatment of fibrosis | |
IL272032A (en) | Methods of treatment for cystic fibrosis | |
IL271181A (en) | Methods of treatment for cystic fibrosis | |
HK1232147A1 (en) | Cenicriviroc for the treatment of fibrosis | |
HK1258396A1 (en) | Cenicriviroc combination therapy for the treatment of fibrosis | |
IL252839A0 (en) | Treatment of pemphigus | |
IL250960A0 (en) | Cenicriviroc combination therapy for the treatment of fibrosis | |
EP3204007C0 (en) | Triazolopyridine compounds and methods for the treatment of cystic fibrosis | |
EP2968285A4 (en) | Compounds and methods for the treatment of cystic fibrosis | |
SG11201506309SA (en) | Eye massager | |
HK1251166A1 (en) | Targeted treatment of leiomyosarcoma | |
HK1205924A1 (en) | Eye massager | |
GB201416832D0 (en) | Methods of treatment | |
HK1244692A1 (en) | Methods of treating fibrosis | |
HK1247558A1 (en) | Cenicriviroc for the treatment of fibrosis | |
HK1249866A1 (en) | Methods of treatment with taselisib | |
IL251350A0 (en) | Treatment of rett syndrome | |
GB201412010D0 (en) | Treatment of hypertransaminasemia | |
GB201403630D0 (en) | Treatment of cystic fibrosis with alginate oligomers | |
GB201721718D0 (en) | Treatment of cystic fibrosis | |
HK1246718A1 (en) | Compounds for treatment of cystic fibrosis | |
GB201407806D0 (en) | Treatment of fibrosis | |
AU2014904206A0 (en) | Treatment of fibrosis | |
GB201409159D0 (en) | Prediction and treatment of progressive fibrosis | |
GB201311713D0 (en) | Cystic fibrosis treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |